Publications
Published on May 28, 2025.
Updated on August 12, 2025.
2025
Non-Small Cell Lung Cancer (NSCLC)
Real-world data on the management of potentially resectable stage IB-IIIA non-small cell lung cancer (NSCLC) in the United Kingdom (UK) in 2023: Early adoption of immune checkpoint inhibitors (ICIs).
ASCO 2025 - Abstract
Authors:
- Christine Maï
- Andrei Seferian
- Paul Taylor
- Elodie Schneider
- Bertrand De Buhren
- Sébastien Viard
2025
NSCLC
Experiences of patients with advanced ALK+ non-small-cell lung cancer (NSCLC) in France: results of the qualitative phase of the “Living with ALK+ cancer” survey.
Qualitative study conducted by APLUSA.
CPLF (French Language Pulmonology Congress) - Poster
Authors:
- Jacques Cadranel
- Romain Corre
- Peggy Roget
- Sandrine Alliaume
- Mikael Wingler
- Diane Charleux-Muller
- Leslie Capdevielle
- Joana Mendes
- Alice Mogenet
- Bertrand Mennecier
2024
Multiple Myeloma
Key drivers for treatment choice in lenalidomide-exposed and refractory multiple myeloma patients in the real world. Analysis conducted in the EU5 countries and the US.
ASH 2024 - Abstract and poster
Authors:
- Nicolas Blin
- Christine Maï
- Siegfried Ertl
- Elodie Schneider
- Marine Leberre
- Mélissa Yilmaz
- Alexandre Raffy
2024
Diffuse Large B-Cell Lymphoma
Estimating the impact on survival of not receiving CAR-T therapy despite being eligible in Relapsed/Refractory (R/R) diffuse large B-Cell lymphoma (dlbcl) patients in Germany.
ASH 2024 - Abstract and poster
Authors:
- Veit Bücklein
- Francis A. Ayuk
- Tobias A.W. Holderried
- Christine Maï
- Bradley Kievit
- Rob Blissett
- Brett Doble
- Geoff Reid
- Laura Reimeir
- Caroline Bruns
- Sachin Vadgama
2024
Myasthenia Gravis
Revealing overlooked symptoms of myasthenia gravis: findings from patient national survey in France.
ISPOR 2024 - Abstract and poster
Authors:
- Saskia Bresch
- Annie Archer
- Pierre Boulanger
- Julie Deléglise
- Clémence D'Aietti
- Pascale Bausson
- Ekbel Amri
2024
Acute Myeloid Leukemia
Real world treatment of newly diagnosed patients with acute myeloid leukemia and aged between 60 and 75 years. Analysis of key drivers for chemotherapy selection in France and Germany.
ISPOR 2024 - Abstract and poster
Authors:
- Christine MaÏ
- Nicolas Blin
- Stéphane Deniau
- Marion Voute
- Bertrand De Buhren
- Mélissa Yilmaz
